Introduction

Multimorbidity, commonly defined as the coexistence of two or more chronic conditions within an individual [1, 2], is becoming one of the major challenges for health systems worldwide. According to a review including 41 articles, the prevalence of multimorbidity accounts for 20–30% of the whole population and 55–98% when the elderly are considered globally [3]. In the United States, a national survey showed that 59.6% of adults had multimorbidity in 2014 [4]. The proportion of patients with four + diseases is expected to double between 2015 and 2035 in the United Kingdom [5]. A large epidemiological survey in China found that 46.5% of residents had several chronic diseases as multimorbidity [6]. The prevalence is higher among very elderly people, women, and people with lower social classes [3, 4]. Multimorbidity is highly associated with increased risks of premature death, hospitalization, loss of physical functioning, depression, polypharmacy, and worsening quality of life, thus resulting in a substantial economic burden on health systems [7]. Multimorbidity patients had a 73% (HR: 1.73, (95% CI: 1.41, 2.13)) [8] increased risk of death and a 94% (1.94, (1.43, 2.63)) [9] increased risk of functional limitation compared with non-multimorbidity patients.

Several modifiable lifestyles, such as smoking, long-term sitting and obesity, are found to be risk factors for multimorbidity [10, 11]. The promotion of healthy behavior, especially adherence to a healthy diet, has been shown to be effective for preventing multimorbidity [12]. Currently, research on the relationship between nutrition (such as dietary patterns, consumed main foods, nutrient intake) and multimorbidity has been reported in several studies. A cross-sectional exploratory study from China reported that unhealthy dietary behaviors such as over-eating and intra-meal water drinking were linked to an increased risk of cardiometabolic multimorbidity [13]. Another cross-sectional study conducted in the Netherlands found that adults with cardiometabolic multimorbidity consumed more meat and snacks [14]. According to a Chinese cohort study, greater consumption of fruits, vegetables, and whole grain products appears to lower the risk of multimorbidity [15]. It has been reported that higher adherence to the Mediterranean diet was associated with a lower risk of multimorbidity [16, 17], and the Mediterranean diet may contribute to protecting geriatric patients with multimorbidity from developing depressive symptoms [18]. Yue Zhang et al. [19] found that a white meat pattern characterized by consumption of fish and poultry is associated with reduced risks of multimorbidity, while more frequent intake of poultry, the specific food group, was related to higher risks. Generally, most present evidence remains cross-sectional, and the number of cohorts is still limited, especially regarding nutrient intake. A cross-sectional study from South Korea found that calcium and potassium were associated with a lower cardiometabolic multimorbidity pattern [20]. Another cross-sectional study reported that lutein and zeaxanthin intake may be good for one’s health, whereas increasing niacin intake may be likely to raise 10-year mortality according to the Charlson comorbidity index (CCI) [21]. At present, the conclusions are still limited, and more high-quality longitudinal studies need to be conducted.

The aim of this study was to investigate the relationship between nutrients and multimorbidity. Knowledge about the dietary factors associated with multimorbidity has important implications for prevention, diagnosis, treatment and prognosis strategies. The results of this study can contribute to the development of interventions targeting healthy dietary choices when managing multimorbidity.

Methods

Study design

Our research analysis is mainly based on the data collected by the United Kingdom Women’s Cohort Study (UKWCS), which has been described in detail in previous literature [22]. The UKWCS initially recruited 35,372 women aged 35–69 years at baseline (1995 to 1998), aiming to explore potential associations between diet and chronic diseases. The dataset in the UKWCS included food consumption, anthropometric measures, socioeconomic status, lifetime lifestyle and health outcomes. Baseline chronic diseases were self-reported by participants including coronary heart disease, angina, stroke, hypertension, hyperlipidemia, diabetes, gallstones, polyps of the large intestine, and any cancers. Considering chronic diseases listed above may make participants more susceptible to multimorbidity during follow-ups, we excluded participants with two or more chronic diseases at baseline in our analyses. Relatively, those living with one chronic disease which were generally not influential were included (n = 6,280). The UKWCS has been approved by the National Research Ethics Service (NRES) Committee for Yorkshire & the Humber– Leeds East (Ref: 15/YH/0027) and was updated by the Health Research Authority REC (Reference: 17/YH/0144) for linkage outcomes and related sub-studies.

Dietary assessment

Baseline dietary data were collected via a self-reported food frequency questionnaire (FFQ) with 217 British food items, which was adapted from the FFQ used in the UK for the European Prospective Investigation into Cancer and Nutrition (EPIC) study [23]. The validation of the FFQ can be seen in previous studies [24]. Food intake frequencies obtained from the FFQ were converted into daily consumed portions for each food item (Supplementary Table 1). Incomplete information on food frequency was assumed that missing items were not consumed. To calculate the weight of each food consumed per day (g/day), daily portions were multiplied by standard portion weights according to the Food Standards Agency portion sizes book [25]. By multiplying the food weight by the standard nutrient composition of foods derived from McCance & Widdowson’s The Composition of Foods (5th Edition) [26], daily energy and nutrient intakes of each food item were calculated and further summed for total energy and nutrients per day consumed for each participant. Nutrient intake from supplements was not accounted for in this study.

The consumption of foods and nutrients was adjusted for total energy using the nutrient density method [27] (for protein, carbohydrates, and fat, the percentage of total energy derived from each one; for other nutrients and foods, the ratio of selected nutrient intake to per MJ of total energy intake). Each energy adjusted intake of nutrients was analyzed in multiple regression models with total energy intake additionally as a covariate using the multivariate nutrient density method recommended by Willett et al. [27].

Measurement of multimorbidity

We assessed multimorbidity using the CCI, which was proposed by British scholar Charlson in 1987 [28], to assess the impact of multimorbidity on the survival rate of patients in the next 10 years in addition to the underlying diseases. The CCI is the most commonly used tool that quantifies multiple comorbidities. It quantifies the impact of 17 comorbidities based on their numbers and individual prognostic impacts by means of a score [28, 29]. The status of multimorbidity conditions was obtained from the electronic linkages to Hospital Episode Statistics up to March 2019, based on International Classification of Diseases, the Tenth edition, Australian modification (ICD-10-AM) [30], and the CCI was calculated using these data. Diagnostic categories and corresponding ICD-10-AM codes are shown in Supplementary Table 2. In this study, the first primary diagnosis of the disease was excluded from calculation of the CCI as recommended [28, 31, 32]. The second diagnosis or more, which matched the ICD-10-AM codes listed in Supplementary Table 2, was given corresponding scores. The total CCI score was obtained by summing each diagnostic score from the same hospitalization record together. The frequency distribution of the CCI score in participants included in this study is shown in Supplementary Table 3. For the purposes of analysis, CCI scores were categorized as 0 (without multimorbidity), 1 (low level), and greater (moderate to high level). Follow-up of each participant continued until the diagnosis of the main outcome (defined as the occurrence of multimorbidity), death from any cause, or end of the censor date (31 March 2019), whichever came first.

Covariates

Baseline sociodemographic information, such as age, ethnicity, educational level, and marital status, was obtained by self-report. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Height and weight were also obtained by self-reporting. Socioeconomic status (SES) was derived from the United Kingdom National Statistics-Socio-Economic Classification (NS-SEC), where participants were classified into three categories (routine/manual, intermediate, or managerial/professional) [33]. Because there were overlapping properties between socioeconomic indicators (education, social class, income, or employment) [34], this study used only SES as an adjustment factor. Participants were asked questions about their daily activities at baseline using the International Physical Activity Questionnaire (IPAQ) short form [35]. According to the official guidelines for data processing and analysis of the IPAQ Short Forms, physical activity was calculated and divided into three levels: low, medium and high. Participants with missing data for any covariates required in the Cox models were excluded, and baseline profiles of nutrient intake were compared between participants with or without missing data in covariates.

Statistical analysis

To better compare baseline characteristics including sociodemographic, lifestyle, anthropometric and nutritional profiles of the UKWCS participants, each CCI score was categorized into 0 (without multimorbidity), 1 (low level), and greater (moderate to high level) as three CCI groups. The baseline characteristics of the participants are expressed as mean (standard deviation, SD) and number (percentage), and compared among different CCI groups using the ANOVA method and Chi-square tests for continuous and categorical variables, respectively.

Cox’s proportional hazards models were used to estimate associations between daily intakes of nutrients and risk of multimorbidity. The CCI score for each participant was grouped into without (CCI = 0, as reference) or with (CCI > 0) multimorbidity in the COX models. The exposure variables were standardized using a z-score method to make sure comparisons in the same scale, and were further categorized into quintiles of nutrient intake with the lowest quintile (Q1) as the reference. We modeled the median intake of each quintile as a continuous term to test for linear trend. Baseline characteristics were further compared between participants with different intake levels of nutrients that significantly associated with risk of multimorbidity. Adjusted hazard ratios (HR) and 95% confidence intervals (95% CI) in multivariate models for multimorbidity were reported. The covariates included in the multivariate model were age, ethnicity, marital status, SES, physical activity, body mass index, smoking status, alcohol consumption, and total energy intake which were obtained from baseline survey. In this study, the total energy intake was omitted from the covariate set when the exposure factor was energy intake. We conducted subgroup analyses with age 60 as the cutoff point. Interactions terms were tested using the Wald test. In addition, sensitivity analyses were conducted using multinomial logistic regression to test robustness of our results with the CCI = 0 as the base outcome of three CCI groups and each continuous nutrient intake as the exposure. All analyses were carried out using Stata version 17.0, and p < 0.05 was considered significant.

Results

Socioeconomic characteristics

Of the 35,372 women recruited at recruitment, 3,821 not resident in England, 2,629 living with two or more chronic diseases at baseline, and 3,533 with missing data in covariates were excluded, leaving 25,389 women for analyses in this study (Fig. 1). The mean age of the 25,389 participants was 51 (SD = 9) years. During a mean follow-up of 20 (SD = 5) years (median: 22 years), subjects with a diagnosis of multimorbidity comprised 30.7% of the final study population, including 19.5% with low levels and 11.2% with moderate to high levels. Among the 25,389 participants, 25,080 (98.8%) were White, 131 (0.52%) were Asian, 37 (0.15%) were Black, and 141 (0.60%) were other races. Participants without multimorbidity had a higher educational level and higher levels of SES than their counterparts with multimorbidity (Table 1). Participants with multimorbidity had higher BMI, more ex-smokers and current smokers and were more likely to be single or widowed than those without multimorbidity (Table 1). In addition, although there was a 3-year difference in baseline age, characteristics of most nutrient intake between participants with or without missing covariate data show no significant difference (Supplementary Table 4).

Fig. 1
figure 1

Flow chart of selection of the study population

Table 1 Demographic characteristics within the UK Women’s Cohort Study*

Dietary intake of nutrients

The characteristics of nutrient intake by CCI group are summarized in Table 2. Women without multimorbidity had higher intakes of vitamin B1 and vitamin E but lower intakes of vitamin B2, vitamin B6 and vitamin A than those with different levels of multimorbidity (Table 2). There was little difference in the remaining nutrient intake between the three CCI groups.

Table 2 Profiles of nutrient intake within the UK Women’s Cohort Study

Associations between nutrient intake and multimorbidity risk

The associations between intakes of energy and nutrients and risk of multimorbidity are shown in Fig. 2. Women in the highest quintile of energy and protein intake had 8% and 12% increased risk of multimorbidity respectively compared with women in the lowest quintile (1.08 (1.01, 1.16), p-linearity = 0.022 for energy; 1.12 (1.04, 1.21), p-linearity = 0.003 for protein). Compared to the lowest quintile, higher quintiles of daily vitamin C intake had around 10% lowered risk of multimorbidity (p-linearity = 0.044), while daily vitamin D intake had around 10% increased risk of multimorbidity (p-linearity = 0.002).

Fig. 2
figure 2

Associations of nutrient intake and risk of multimorbidity within the UK Women’s Cohort Study. The multivariate models adjusted for age, ethnicity, marital status, socioeconomic status, physical activity, body mass index, smoking status, alcohol consumption, and total energy intake. MJ, mega joule; SFAs, saturated fatty acids; PUFAs, polyunsaturated fatty acids; MUFAs, monounsaturated fatty acids. Original data for Fig. 2 were supplemented as Supplementary Table 6 of Appendix 2

Compared with the lowest quintile of vitamin B12 intake, the risk of multimorbidity was significantly increased in the highest vitamin B12 quintile (1.14 (1.05, 1.22), p-linearity = 0.001). There were some differences in baseline characteristics between participants with different intake levels of nutrients that significantly associated with risk of multimorbidity. For example, compared to participants in the lowest quintile of protein, vitamin B12 and vitamin D intake, those in the highest quintile were more likely to be older, having lower levels of education and SES, having a higher BMI, and less likely to be separated or divorced (Supplementary Table 5). For most other nutrients, no significant associations with multimorbidity risk have been found in this study.

Subgroup analysis and sensitivity analysis

For the subgroup analysis in Fig. 3, there was some evidence of effect modification by age in intakes of vitamin B1 and iron (p-interaction = 0.025 and 0.006,) respectively, where there were different trends of association with risk of multimorbidity between participants who were < 60 and ≥ 60 years. For intakes of iron, it was associated with a 11–13% lower risk of multimorbidity in participants aged < 60 years (p-interaction = 0.006) only. There was no significant evidence of effect modification by age in intakes of the remaining nutrients (Fig. 3). The results of sensitivity analyses shown in Supplementary Table 7 generally did not contradict our main results. Some nutrients that significantly associated with multimorbidity in COX models became statistically insignificant.

Fig. 3
figure 3

Subgroup analysis by age on associations between nutrient intake and risk of multimorbidity within the UK Women’s Cohort Study. Adjusted for age, ethnicity, marital status, socioeconomic status, physical activity, body mass index, smoking status, alcohol consumption, and total energy intake. P-interaction represents the statistical significance for interaction item of dietary factors and age where age was modelled linearly in the Cox proportional regression. 95%CI, 95% Confidence Interval; MJ, mega joule; SFAs, saturated fatty acids; PUFAs, polyunsaturated fatty acids; MUFAs, monounsaturated fatty acids. Original data for Fig. 3 were supplemented as Supplementary Table 8 of Appendix 2

Discussion

In this study, we found that daily intake of energy and protein was associated with 8% and 12% higher risk of multimorbidity. Daily intake of vitamin C had about 10% lowered risk of multimorbidity, while daily intake of vitamin D had about 10% increased risk of multimorbidity. A significantly higher risk of multimorbidity was found to be associated with the consumption of vitamin B12 in this cohort of UK women. Subgroup analysis showed an effect modification by age in associations between intakes of iron and vitamin B1 and risk of multimorbidity. However, vitamin D and vitamin B12 that significantly associated with multimorbidity in COX models became statistically insignificant in sensitivity analyses, indicating some uncertainty in those associations. We considered it may be caused by the absence of follow-up time periods in multinomial logistic regression analyses, which potentially attenuated the statistical testing power.

Daily intakes of protein increased the multimorbidity risk in our study. Proteins can be absorbed if they are hydrolyzed into amino acids and peptides, which are building blocks of proteins. Recently, studies have indicated that amino acids are potential metabolites that have been associated with aging-related diseases and higher risks of impaired physical functions [36, 37]. Consistent with our report, a population-based cohort study reported that higher concentrations of glutamine and branched-chain amino acids such as isoleucine and valine were associated with higher levels of multimorbidity [38].

At present, the association between iron intake and risk of multimorbidity remains controversial across previous research. Our study showed a negative correlation between iron intake and risk of multimorbidity only in participants aged < 60 years old. A community-based longitudinal study in Malaysia indicated that a one-point increase in daily intakes of iron (mg/day) was associated with decreased chance of developing multimorbidity by 8% among one-disease participants at baseline [39]. In addition, a Chinese study found that daily consumption of iron (mg/day) was lower in people with multimorbidity than in those with one chronic disease or healthy individuals [15]. The result of our subgroup analysis in participants aged < 60 years old is in agreement with these studies. However, high concentrations of labile iron are highly toxic to the cell by generating reactive oxygen species (ROS) that may inflict damage on cells and organs [40]. It was reported that high concentrations of labile iron are highly associated with increased risk of cancer, diabetes, neurodegenerative diseases, liver disease, kidney disease, bone disorders and cardiovascular diseases [41]. Iron seems to accumulate in an age-related and tissue/organ-specific manner, while ferritin levels increase with age [42, 43]. The rate of iron accumulation is proportional to the rate of aging [44]. This might explain why a protective association between iron intake and the risk of multimorbidity was observed in participants aged < 60 years rather than those aged ≥ 60 years in this study.

In our study, we found that higher intakes of vitamin B12 was associated with higher risk of multimorbidity. Although there are few studies that directly looked at associations between vitamin B12 and multimorbidity, the relationship between vitamin B12 and certain diseases plays a role in indirect explanation. Related research has found that high concentrations of vitamin B12 were associated with all-cause mortality [45, 46] and cancer diagnosis/mortality [47]. A prospective longitudinal study named Newcastle 85 + Study from Northeast England found that plasma vitamin B12 in women was associated with an increased risk of mortality in the very elderly [48]. More recently, a study reported that high vitamin B12 intake and high vitamin B12 status were associated with a higher risk of lung cancer [49,50,51]. Considering that vitamin B12 plays a key role in one-carbon metabolism [52], vitamin B12 is potentially associated with the pathological process of cardiovascular diseases and all-cause mortality. Although potential mechanisms remain unclear, a high level of vitamin B12 in the plasma may result from increased release or decreased clearance of vitamin B12, diminished binding affinity of vitamin B12 for transporter proteins, or upregulation of haptocorrin and transcobalamin synthesis [53, 54].

Recent research has suggested that low levels of vitamin D in plasma are associated with many acute and chronic diseases, such as allergies, depression, cardiovascular disease and cancers [55,56,57]. A cross-sectional study reported that low plasma vitamin D levels were associated with a higher prevalence of multimorbidity [58]. However, these results differed from ours. The decreasing concentration of 7-dehydrocholesterol in the skin with aging results in a 50% reduction in pre-vitamin D synthesis by older people in response to UV light [59]. Especially in the UK where sunlight time is relatively shorter, sunlight exposure and skin synthesis are probably not enough. Requirements for specific nutrients such as vitamin D are unlikely to be met by the diet alone [60]. Therefore, additional supplements of vitamin D are needed to prevent deficiency. However, our study did not include supplemental intake in the analyses due to incomplete records, which may have contributed to the inconsistent results.

Vitamin C was linked with decreased risk of multimorbidity in this study. Vitamin C is an essential dietary nutrient, which has antioxidant roles and is one of the important antioxidants in human plasma [61, 62]. Kidney failure, peritoneal dialysis, hemodialysis, and various malabsorption disorders are risk factors for a low level of endogenous vitamin C and poor dietary intake of vitamin C in the elderly [63]. Among older individuals with an intake below 75 mg/day, the incidence of various chronic diseases such as diabetes and stroke, was associated with reduced vitamin C intake and plasma status [64, 65]. Although few studies have been reported on associations between vitamin C intake and risk of multimorbidity. Several cross-sectional studies have reported that diets high in fruits and vegetables were associated with a lower risk of multimorbidity [66, 67]. Vegetables and fruits are rich in phytochemicals and nutrients, such as vitamin C and dietary fiber, which may be beneficial to multimorbidity, which potentially supported our results.

Strengths and limitations

There are several strengths of this study. First, our study used data from a representative sample with a large number of participants and a long follow-up. Second, the linkage to hospital records made it possible to obtain information about most diseases occurred during follow-ups, and minimize loss to follow-up. Third, wide ranges of potential covariates were controlled to provide a better estimate of associations between nutrient intake and risk of multimorbidity.

However, several limitations should also be considered. First, our study did not analyze supplement intake, which may result in biased estimates. Second, our study was restricted to participants of UKWCS that recruited female individuals only, and may therefore not be generalizable to the general population. However, previous studies have shown gender inequality in multimorbidity, where women tend to face a higher risk of multimorbidity than men [68]. Elderly women with lower SES and higher BMI tend to be at higher risk for multimorbidity [68, 69]. Our female cohort is consistent with the fact that women are at high risk for multimorbidity. Third, although many baseline characteristics have been adjusted for as covariates in survival models, there still were some confounders not being fully adjusted for which may result in some bias. Forth, we didn’t exclude participants who were living with one chronic disease at baseline. Participants who have one chronic disease at baseline were more likely to have multimorbidity, which might potentially impact our results. Fifth, this study is mainly made of White ethnic group people (> 98%), which limits our results’ generalizability to other ethnic groups. Therefore, the findings need to be interpreted with caution.

Implications for policy and practice

Most nutrients are commonly considered beneficial, in particular when they are deficient for individuals. However, our study showed adverse findings for multimorbidity which throws a new aspect of nutrients. The nutrients associated with increased risks of multimorbidity at a higher intake in this study indicated there might be an optimal level of nutrient intakes. The optimal levels of nutrients for individuals with multimorbidity should be further explored, and personalized nutrition should be considered for policy makers and clinical practice. Further clinical trials are needed to determine whether a dietary intervention could exert a beneficial impact on multimorbidity.

Conclusions

In conclusion, our findings suggest some associations between nutrient intake and risk of multimorbidity. Higher intakes of vitamin B12, vitamin D, protein, and energy may be associated with a high risk of multimorbidity. Conversely, higher intake of vitamin C may be associated with a lower risk of multimorbidity. Daily intake of iron was negatively associated with multimorbidity risk in women aged < 60 years old. There was no evidence of an association between iron intake and multimorbidity in women aged ≥ 60 years in this study. Our findings highlight that some nutrients potentially play a role in risk of multimorbidity, especially vitamin B12, vitamin D, as well as protein and energy.